中文名 | GSK503 |
英文名 | GSK503 |
别名 | 化合物GSK503 EZH2甲基转移酶抑制剂(GSK503) N-[(4,6-二甲基-2-氧代-1,2-二氢-3-吡啶基)甲基]-3-甲基-1-(异丙基)-6-[6-(4-甲基-1-哌嗪基)-3-吡啶基]-1H-吲哚-4-甲酰胺 |
英文别名 | GSK03 GSK503 GSK 503 CS-1698 GSK-503 GSK-503,EZH2 inhibitor N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-3-methyl-6-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide N-[(4,6-Dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-(1-methylethyl)-6-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide |
CAS | 1346572-63-1 |
化学式 | C31H38N6O2 |
分子量 | 526.67 |
密度 | 1.24±0.1 g/cm3(Predicted) |
沸点 | 798.6±60.0 °C(Predicted) |
溶解度 | DMSO: ≥ 44 mg/mL |
酸度系数 | 11.93±0.10(Predicted) |
存储条件 | -20℃ |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.899 ml | 9.494 ml | 18.987 ml |
5 mM | 0.38 ml | 1.899 ml | 3.797 ml |
10 mM | 0.19 ml | 0.949 ml | 1.899 ml |
5 mM | 0.038 ml | 0.19 ml | 0.38 ml |